Caplyta

Caplyta (lumateperone) is a prescription medication used to treat Schizophrenia, bipolar depression. A once-daily oral antipsychotic for schizophrenia and for depressive episodes of bipolar I and II disorder.

Acts on serotonin, dopamine, and glutamate pathways to help stabilize mood and reduce psychotic symptoms.

Commonly reported side effects of Caplyta include Drowsiness, Dry mouth, Dizziness, Nausea, and Increased mortality in dementia patients. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Caplyta carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Caplyta is lumateperone, which belongs to a class of medicines known as Atypical Antipsychotic.

Caplyta is manufactured by Intra-Cellular Therapies. It was first approved in 2019.

You may be able to lower the cost of Caplyta by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.